Mayne Pharma Group Ltd MAYNF
$2.29
Last Updated: Aug 13, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
MAYNF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Mayne Pharma Group Ltd is classified as halal.
HALAL
Report Source: undefined Quarter Report
Mayne Pharma Group Ltd. Stock Analysis MAYNF
United States Health Care Micro Cap Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. The company is headquartered in Adelaide, South Australia and currently employs 450 full-time employees. The company went IPO on 2007-06-29. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The firm's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others. Its subsidiaries include Mayne Pharma International Pty Ltd, Mayne Holdings US Inc, Mayne Pharma LLC, and others.
Mayne Pharma Group Ltd (MAYNF) Chart
Financial Metrics & Statements of Mayne Pharma Group Ltd (MAYNF)
FAQ's for Mayne Pharma Group Ltd (MAYNF)
- As of August 2026, Mayne Pharma Group Ltd MAYNF is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Mayne Pharma Group Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Mayne Pharma Group Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Mayne Pharma Group Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Mayne Pharma Group Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Mayne Pharma Group Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Mayne Pharma Group Ltd (MAYNF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
